Integrated Filing — IndAS



General information about company

Scrip Code 543524
NSE Symbol RAINBOW
MSEI Symbol NOTLISTED
ISIN INE961O01016
Name of company Rainbow Childrens Medicare Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 23-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 15-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment The business of running multi specialty pediatric and obstetrics and gynecology hospital.
Start date and time of board meeting 23-05-2026   16:45:00
End date and time of board meeting 23-05-2026   18:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 09-02-2025
Indicate Company website link for updated RPT policy of the Company https://d31scedd5hpubp.cloudfront.net/investor_files/Policy_on_Materiality_and_Dealing_with_Related_Party_TransactionsFEB2025.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
As per results attached there are no default on loans and debt securities.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 40,806.40 1,54,566.00
Other income 524.00 4,345.40
Total income 41,330.40 1,58,911.40
2 Expenses
(a) Cost of materials consumed 4,857.20 19,966.90
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 5,661.60 21,239.30
(e) Finance costs 1,852.40 7,139.60
(f) Depreciation, depletion and amortisation expense 3,565.20 13,626.10
(f) Other Expenses
1 Professional fees to doctors 9,861.90 37,706.50
2 Canteen expenses 625.60 2,540.30
3 Contract wages 1,214.50 4,410.70
4 Housekeeping expenses 216.60 800.80
5 Power and fuel 591.50 2,603.00
6 Lab and investigations 428.90 1,607.60
7 Repairs and maintenance 710.60 3,107.80
8 Rates and taxes 489.90 1,819.40
9 Business promotion and advertisement 824.50 2,397.60
10 Other Expenses 2,430.00 6,380.40
Total other expenses 17,394.00 63,374.10
Total expenses 33,330.40 1,25,346.00
3 Total profit before exceptional items and tax 8,000.00 33,565.40
4 Exceptional items (153.90) (153.90)
5 Total profit before tax 7,846.10 33,411.50
6 Tax expense
7 Current tax 2,303.70 9,143.70
8 Deferred tax (388.10) (733.80)
9 Total tax expenses 1,915.60 8,409.90
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 5,930.50 25,001.60
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 5,930.50 25,001.60
17 Other comprehensive income net of taxes (49.90) (66.10)
18 Total Comprehensive Income for the period 5,880.60 24,935.50
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 10,155.90 10,155.90
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 1,58,749.80
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 5.85 24.62
Diluted earnings (loss) per share from continuing operations 5.85 24.62
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 5.85 24.62
Diluted earnings (loss) per share from continuing and discontinued operations 5.85 24.62
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) For notes please refer Results filing



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1,44,855.40
Capital work-in-progress 7,566.10
Investment property 0.00
Goodwill 0.00
Other intangible assets 941.90
Intangible assets under development 347.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 21,769.90
Trade receivables, non-current 0.00
Loans, non-current 6,590.90
Other non-current financial assets
1 Other financial assets 14,153.10
Total of other non-current financial assets 14,153.10
Total non-current financial assets 42,513.90
Deferred tax assets (net) 3,615.40
Other non-current assets
1 Non-current tax assets (net) 1,369.50
2 Other non-current assets 3,967.50
Total of other non-current assets 5,337.00
Total non-current assets 2,05,176.70
2 Current assets
Inventories 2,990.60
Current financial asset
Current investments 37,143.00
Trade receivables, current 10,035.00
Cash and cash equivalents 1,728.00
Bank balance other than cash and cash equivalents 0.50
Loans, current 504.30
Other current financial assets
Total of other current financial assets 4,927.70
Total current financial assets 54,338.50
Current tax assets (net)
Other current assets
1 Other current assets 2,332.90
Total of other current assets 2,332.90
Total current assets 59,662.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 2,64,838.70
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 10,155.90
Other equity 1,58,749.80
Total equity attributable to owners of parent 1,68,905.70
Non controlling interest
Total equity 1,68,905.70
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease liabilities 77,843.40
Total of other non-current financial liabilities 77,843.40
Total non-current financial liabilities 77,843.40
Provisions, non-current 0.00
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 77,843.40
Current liabilities
Current financial liabilities
Borrowings, current 1,529.50
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2,531.80
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 6,208.60
Total Trade payable 8,740.40
Other current financial liabilities
1 lease liabilities 2,292.80
2 Other current financial liabilities 2,407.80
Total of other current financial liabilities 4,700.60
Total current financial liabilities 14,970.50
Other current liabilities 3,119.10
1 Other current liabilities 2,632.30
2 Deferred tax liabilities 486.80
Total of other current liabilities 3,119.10
Provisions, current 0.00
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 18,089.60
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 95,933.00
Total equity and liabilites 2,64,838.70
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) For Notes please refer results



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement (loss)/gain on defined benefit obligation (66.70) (88.30)
Total Amount of items that will not be reclassified to profit and loss (66.70) (88.30)
2 Income tax relating to items that will not be reclassified to profit or loss (16.80) (22.20)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income (49.90) (66.10)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 33,411.50
Adjustments for reconcile profit (loss)
Adjustments for finance costs 7,139.60
Adjustments for decrease (increase) in inventories (716.40)
Adjustments for decrease (increase) in trade receivables, current (2,676.50)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1,622.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 812.80
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 13,626.10
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 487.70
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (6.40)
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 291.20
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (2,468.20)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (673.70)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 14,194.20
Net cash flows from (used in) operations 47,605.70
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 9,514.60
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 38,091.10
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 20,360.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 128.90
Purchase of property, plant and equipment 19,989.40
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 1,279.60
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 14,795.60
Net cash flows from (used in) investing activities (24,145.30)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 1,585.40
Dividends paid 3,046.50
Interest paid 7,146.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (2,128.90)
Net cash flows from (used in) financing activities (13,906.80)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 39.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 39.00
Cash and cash equivalents cash flow statement at beginning of period 0.00
Cash and cash equivalents cash flow statement at end of period 39.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 S.R. BATLIBOI & ASSOCIATES LLP Yes 31-07-2027


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Rainbow Children's Medicare Limited Mr. Ramadhara Naidu Kancharla Brother of Key Managerial Personnel (KMP) Purchase of goods or services 60.00 NA 30.00 0.00 5.40 Textual Information(1)
2 Rainbow Children's Medicare Limited Mr. Ramadhara Naidu Kancharla Brother of Key Managerial Personnel (KMP) Any other transaction Reimbursement of expenses 20.00 Approved by Audit Committee 1.90 0.00 0.00
3 Rainbow Children's Medicare Limited Ravindranath GE Medical Associates Private Limited Enterprises where key managerial personnel along with their relatives exercise significant influence Purchase of goods or services 100.00 Approved by Audit Committee 0.00 0.00 0.00
4 Rainbow Children's Medicare Limited Rainbow Speciality Hospitals Private Limited Subsidiary Purchase of goods or services 100.00 Approved by Audit Committee 3.10 0.00 0.00
5 Rainbow Children's Medicare Limited Rainbow Speciality Hospitals Private Limited Subsidiary Any other transaction Medical Service fee paid 100.00 Approved by Audit Committee 11.10 0.00 0.00
6 Rainbow Children's Medicare Limited Rainbow Speciality Hospitals Private Limited Subsidiary Any other transaction Rent paid 17.50 Approved by Audit Committee 21.00 0.00 0.00
7 Rainbow Children's Medicare Limited Rainbow Speciality Hospitals Private Limited Subsidiary Any other transaction Reimbursement of expenses 100.00 Approved by Audit Committee 0.00 0.00 0.00
8 Rainbow Children's Medicare Limited Rainbow Speciality Hospitals Private Limited Subsidiary Sale of goods or services 100.00 Approved by Audit Committee 44.80 0.00 0.00
9 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly Owned Subsidiary Inter-corporate deposit 500.00 Approved by Audit Committee 0.00 100.00 100.00
10 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly Owned Subsidiary Any other transaction Accrued Interest on Inter Corporate Deposits 47.50 Approved by Audit Committee 4.10 1.80 5.90
11 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly Owned Subsidiary Any other transaction Rent Received 1.50 Approved by Audit Committee 11.50 1.90 1.90
12 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly Owned Subsidiary Any other transaction Security Deposit 0.70 Approved by Audit Committee 0.00 0.70 0.70
13 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly Owned Subsidiary Purchase of goods or services 100.00 Approved by Audit Committee 280.00 105.90 0.00
14 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly Owned Subsidiary Sale of goods or services 400.00 Approved by Audit Committee 120.20 423.30 280.00
15 Rainbow Children's Medicare Limited Rainbow CRO Private Limited Wholly Owned Subsidiary Sale of goods or services 10.00 Approved by Audit Committee 0.00 0.40 0.40
16 Rainbow Children's Medicare Limited Rainbow Children's Foundation Enterprises where key managerial personnel along with their relatives exercise significant influence Sale of goods or services 100.00 Approved by Audit Committee 16.30 1.00 0.00
17 Rainbow Children's Medicare Limited Unimed Healthcare Private Limited Enterprises where relative of key managerial personnel is a member Any other transaction Security Deposit 300.00 Approved by Audit Committee 0.00 300.00 300.00
18 Rainbow Children's Medicare Limited Unimed Healthcare Private Limited Enterprises where relative of key managerial personnel is a member Any other transaction Reimbursement of expenses 250.00 Approved by Audit Committee 101.00 0.00 1.50
19 Rainbow Children's Medicare Limited Unimed Healthcare Private Limited Enterprises where relative of key managerial personnel is a member Sale of goods or services 500.00 Approved by Audit Committee 8.20 10.80 3.50
20 Rainbow Children's Medicare Limited Unimed Healthcare Private Limited Enterprises where relative of key managerial personnel is a member Purchase of goods or services 100.00 Approved by Audit Committee 95.20 24.60 63.80
21 Rainbow Children's Medicare Limited Unimed Healthcare Private Limited Enterprises where relative of key managerial personnel is a member Any other transaction Rent paid 600.00 Approved by Audit Committee 272.00 49.00 22.50
22 Rainbow Children's Medicare Limited Rainbow Children's Hospital Foundation Enterprises where key managerial personnel along with their relatives exercise significant influence Any other transaction CSR spent on behalf of Rainbow Children's Medicare Limited 360.00 Approved by Audit Committee 77.70 0.00 0.00
23 Rainbow Children's Medicare Limited Dr. Ramesh Kancharla Chairman and Managing Director Remuneration NA 227.50 0.00 0.00 Textual Information(2)
24 Rainbow Children's Medicare Limited Dr. Ramesh Kancharla Chairman and Managing Director Any other transaction Travel Advance NA 11.80 29.10 13.10 Textual Information(3)
25 Rainbow Children's Medicare Limited Dr. Dinesh Kumar Chirla Whole Time Director Purchase of goods or services 600.00 Approved by Audit Committee 158.00 0.00 25.20
26 Rainbow Children's Medicare Limited Dr. Adarsh Kancharla Non-Executive Director Any other transaction Board and Committee Meeting Sitting Fee NA 0.00 0.00 0.00 Textual Information(4)
27 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly Owned Subsidiary Purchase of goods or services 150.00 Approved by Audit Committee 0.00 0.00 0.00
28 Rainbow Children's Medicare Limited Dr. Sai Aishwarya Chirla Relative of KMP Purchase of goods or services Approved by Audit Committee 1.20 0.00 0.70
29 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Any other transaction Investment in Share Capital of Subsidiary NA 0.00 2,485.20 0.00 Textual Information(5)
30 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Any other transaction Investment in NCRPS (Equity Component) NA 0.00 259.50 0.00 Textual Information(6)
31 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Any other transaction Investment in NCRPS (Loan Component) NA 21.90 526.20 548.10 Textual Information(7)
32 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Interest received Approved by Audit Committee 14.90 1.80 16.70
33 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Inter-corporate deposit Approved by Audit Committee 200.00 200.00 400.00
34 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Sale of goods or services Approved by Audit Committee 67.00 0.00 0.00
35 Rainbow Children's Medicare Limited Pratiksha Women & Child Care Hospital Private Limited Subsidiary Any other transaction Investment in Share Capital of Subsidiary NA 0.00 12,996.00 12,996.00 Textual Information(8)
36 Rainbow Children's Medicare Limited Pratiksha Women & Child Care Hospital Private Limited Subsidiary Any other transaction Investment in NCRPS (Equity Component) NA 0.00 1,374.70 1,374.70 Textual Information(9)
37 Rainbow Children's Medicare Limited Pratiksha Women & Child Care Hospital Private Limited Subsidiary Any other transaction Investment in NCRPS (Loan Component) NA 116.00 2,758.30 2,874.30 Textual Information(10)
38 Prashanthi Medicare Private Limited Rosewalk Healthcare Private Limited Enterprises where key managerial personnel along with their relatives exercise significant influence Any other transaction Rent Approved by Audit Committee 0.30 0.10 0.00
39 Pratiksha Women & Child Care Hospital Private Limited Rosewalk Healthcare Private Limited Enterprises where key managerial personnel along with their relatives exercise significant influence Any other transaction Rent Approved by Audit Committee 1.40 0.00 0.00
40 Prashanthi Medicare Private Limited Rosewalk Healthcare Private Limited Enterprises where key managerial personnel along with their relatives exercise significant influence Purchase of goods or services Approved by Audit Committee 0.90 0.00 0.00
41 Pratiksha Women & Child Care Hospital Private Limited Rosewalk Healthcare Private Limited Enterprises where key managerial personnel along with their relatives exercise significant influence Purchase of goods or services Approved by Audit Committee 1.70 0.00 0.00
42 Pratiksha Women & Child Care Hospital Private Limited Coras Pratiksha Orthopaedic Hospital Enterprises where key managerial personnel along with their relatives exercise significant influence Sale of goods or services Approved by Audit Committee 155.00 0.00 58.00
43 Pratiksha Women & Child Care Hospital Private Limited Coras Pratiksha Orthopaedic Hospital Enterprises where key managerial personnel along with their relatives exercise significant influence Purchase of goods or services Approved by Audit Committee 40.60 0.00 6.90
44 Pratiksha Women & Child Care Hospital Private Limited Coras Pratiksha Orthopaedic Hospital Enterprises where key managerial personnel along with their relatives exercise significant influence Any other transaction Reimbursement of expenditure Approved by Audit Committee 5.80 0.00 0.00
45 Pratiksha Women & Child Care Hospital Private Limited Pratiksha Medicos Enterprises where key managerial personnel along with their relatives exercise significant influence Purchase of goods or services Approved by Audit Committee 79.50 0.00 1.80
46 Pratiksha Women & Child Care Hospital Private Limited Pratiksha Medicare Enterprises where key managerial personnel along with their relatives exercise significant influence Purchase of goods or services Approved by Audit Committee 44.50 0.00 0.00
47 Pratiksha Women & Child Care Hospital Private Limited Pratiksha Hospitals Private Limited Enterprises where key managerial personnel along with their relatives exercise significant influence Any other transaction Rent paid Approved by Audit Committee 119.40 0.00 0.00
48 Pratiksha Women & Child Care Hospital Private Limited Prathiksha Day Care Centre Enterprises where key managerial personnel along with their relatives exercise significant influence Any other transaction Rent paid Approved by Audit Committee 119.40 0.00 0.00
49 Pratiksha Women & Child Care Hospital Private Limited PRAMOD KUMAR SHARMA Director Any other transaction Rent paid Approved by Audit Committee 5.60 0.00 0.00
50 Pratiksha Women & Child Care Hospital Private Limited PRAMOD KUMAR SHARMA Director Purchase of goods or services Approved by Audit Committee 2.40 0.00 0.80
51 Pratiksha Women & Child Care Hospital Private Limited Structures and Earthquake Enterprises where key managerial personnel along with their relatives exercise significant influence Purchase of goods or services Approved by Audit Committee 17.90 0.00 1.80
Total value of transaction during the reporting period 2,510.80



Text Block

Textual Information(1) This was approved by the Board of Directors
Textual Information(2) This was approved by the Board of Directors and Shareholders of the Company
Textual Information(3) This was approved by the Board of Directors and Shareholders of the Company
Textual Information(4) This was approved by the Board of Directors
Textual Information(5) This was approved by the Board of Directors
Textual Information(6) This was approved by the Board of Directors
Textual Information(7) This was approved by the Board of Directors
Textual Information(8) This was approved by the Board of Directors
Textual Information(9) This was approved by the Board of Directors
Textual Information(10) This was approved by the Board of Directors